Source: Revista da Associação Médica Brasileira. Unidades: FO, FM
Assunto: NEOPLASIAS MAMÁRIAS
ABNT
GOBBI, Helenice et al. Challenges in the evaluation of HER2 and HER2-low in breast cancer in Brazil and recommendations of a multidisciplinary working group. Revista da Associação Médica Brasileira, v. 70, n. 10, 2024Tradução . . Disponível em: https://www.scielo.br/j/ramb/a/k76KVyqyLWsbhrsXj9pxMwg/. Acesso em: 17 maio 2025.APA
Gobbi, H., Soares, F. A., Carvalho, F. M., De Brot, M., Logullo, A. F., Silva, C. A. M., et al. (2024). Challenges in the evaluation of HER2 and HER2-low in breast cancer in Brazil and recommendations of a multidisciplinary working group. Revista da Associação Médica Brasileira, 70( 10). doi:10.1590/1806-9282.20240313NLM
Gobbi H, Soares FA, Carvalho FM, De Brot M, Logullo AF, Silva CAM, Landeiro L, Rahal R, Barrios CH. Challenges in the evaluation of HER2 and HER2-low in breast cancer in Brazil and recommendations of a multidisciplinary working group [Internet]. Revista da Associação Médica Brasileira. 2024 ; 70( 10):[citado 2025 maio 17 ] Available from: https://www.scielo.br/j/ramb/a/k76KVyqyLWsbhrsXj9pxMwg/Vancouver
Gobbi H, Soares FA, Carvalho FM, De Brot M, Logullo AF, Silva CAM, Landeiro L, Rahal R, Barrios CH. Challenges in the evaluation of HER2 and HER2-low in breast cancer in Brazil and recommendations of a multidisciplinary working group [Internet]. Revista da Associação Médica Brasileira. 2024 ; 70( 10):[citado 2025 maio 17 ] Available from: https://www.scielo.br/j/ramb/a/k76KVyqyLWsbhrsXj9pxMwg/